Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lyophilized human rabies vaccine (Vero cell) 4-dose (2-1-1) regimen Phase III trial
CTR20200919Phase 3Completed
- Sponsor
- Zhuoyi Biological
- Start
- May 2020
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of rabies vaccine (Vero cells) in rabies, sponsored by Zhuoyi Biological. Started May 2020; status: completed.
02
Drugs
rabies vaccine (Vero cells)
03
Conditions
rabies
Beyond the preview
Go deeper on CTR20200919.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20200919.